XML 33 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Assets:    
Cash and cash equivalents $ 5,193 $ 4,059
Investments 2,334 2,522
Accounts receivable, net 19,789 17,631
Inventories 16,028 16,450
Other current assets 4,841 4,581
Total current assets 48,185 45,243
Long-term investments 17,342 15,732
Property and equipment, net 11,651 11,349
Operating lease right-of-use assets 20,757 0
Goodwill 79,548 78,678
Intangible assets, net 33,655 36,524
Separate accounts assets 4,590 3,884
Other assets 4,385 5,046
Total assets 220,113 196,456
Liabilities:    
Accounts payable 9,442 8,925
Pharmacy claims and discounts payable 13,099 11,365
Health care costs payable 7,014 6,147
Policyholders’ funds 2,938 2,939
Accrued expenses 11,615 10,711
Other insurance liabilities 1,790 1,937
Current portion of operating lease liabilities 1,798 0
Short-term debt 1,070 720
Current portion of long-term debt 3,778 1,265
Total current liabilities 52,544 44,009
Long-term operating lease liabilities 18,826 0
Long-term debt 64,206 71,444
Deferred income taxes 7,279 7,677
Separate accounts liabilities 4,590 3,884
Other long-term insurance liabilities 7,557 8,119
Other long-term liabilities 2,178 2,780
Total liabilities 157,180 137,913
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,725 shares issued and 1,301 shares outstanding at September 30, 2019 and 1,720 shares issued and 1,295 shares outstanding at December 31, 2018 and capital surplus 45,854 45,440
Treasury stock, at cost: 424 shares at September 30, 2019 and 425 shares at December 31, 2018 (28,207) (28,228)
Retained earnings 44,017 40,911
Accumulated other comprehensive income 950 102
Total CVS Health shareholders’ equity 62,614 58,225
Noncontrolling interests 319 318
Total shareholders’ equity 62,933 58,543
Total liabilities and shareholders’ equity $ 220,113 $ 196,456